Zynex, Inc.: 2025 Looks Like A Brighter Year [Seeking Alpha]
Zynex, Inc. (ZYXI)
NASDAQ:AMEX Investor Relations:
zynexmed.com/ir-overview
Company Research
Source: Seeking Alpha
8min Summary Zynex, Inc. focuses on non-opioid pain management and patient monitoring, with a recent FDA approval and a promising product pipeline. Analyst firms remain positive on the company's prospects, and Zynex has a strong balance sheet with no long-term debt and significant insider ownership. Profits will drop significantly in FY2024. However, earnings are projected to rebound sharply in FY2025 as sales growth accelerates. An updated analysis around Zynex, Inc. follows in the paragraphs below. Looking for a helping hand in the market? Members of The Biotech Forum get exclusive ideas and guidance to navigate any climate. Learn More » yodiyim/iStock via Getty Images It has been just over a year since I posted anything on a small medical device maker called Zynex, Inc. ( NASDAQ: ZYXI . I concluded that article by passing on any investment recommendation around this company focused on pain management, due to Live Chat on The Biotech Forum has been dominated by di
Show less
Read more
Impact Snapshot
Event Time:
ZYXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYXI alerts
High impacting Zynex, Inc. news events
Weekly update
A roundup of the hottest topics
ZYXI
News
- Zynex, Inc. (NASDAQ: ZYXI) had its price target raised by analysts at HC Wainwright from $16.00 to $17.00. They now have a "buy" rating on the stock.MarketBeat
- Zynex, Inc. (ZYXI) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Zynex Reports Third Quarter 2024 Financial ResultsPR Newswire
- Zynex Sets Third Quarter 2024 Earnings CallPR Newswire
- Zynex, Inc. (NASDAQ: ZYXI) had its price target lowered by analysts at Royal Bank of Canada from $12.00 to $11.00. They now have an "outperform" rating on the stock.MarketBeat
ZYXI
Sec Filings
- 10/30/24 - Form 144
- 10/29/24 - Form 4
- 10/29/24 - Form 4
- ZYXI's page on the SEC website